Science 16 June 1989: Vol. 244. no. 4910, pp. 1360 - 1362 DOI: 10.1126/science.2660263

Prev | Table of Contents | Next

Articles

Closed-Circuit Xenon Delivery Using a Standard Anesthesia Workstation.

S. Rawat and J. Dingley (2010)
Anesth. Analg. 110, 101-109
 |  Abstract »  |  Full Text »  |  PDF »

Neuroprotective effects of xenon: a therapeutic window of opportunity in rats subjected to transient cerebral ischemia.

H. N. David, B. Haelewyn, C. Rouillon, M. Lecoq, L. Chazalviel, G. Apiou, J.-J. Risso, M. Lemaire, and J. H. Abraini (2008)
FASEB J 22, 1275-1286
 |  Abstract »  |  Full Text »  |  PDF »

Searching for Rational Anti N-methyl-D-aspartate Treatment for Depression Reply.

C. A. Zarate Jr, D. S. Charney, and H. K. Manji (2007)
Arch Gen Psychiatry 64, 1100-1101
 |  Full Text »  |  PDF »

Sigma Receptor Agonists Provide Neuroprotection In Vitro by Preserving bcl-2.

S. Yang, A. Bhardwaj, J. Cheng, N. J. Alkayed, P. D. Hurn, and J. R. Kirsch (2007)
Anesth. Analg. 104, 1179-1184
 |  Abstract »  |  Full Text »  |  PDF »

The Differential Effects of Nitrous Oxide and Xenon on Extracellular Dopamine Levels in the Rat Nucleus Accumbens: A Microdialysis Study.

S. Sakamoto, S. Nakao, M. Masuzawa, T. Inada, M. Maze, N. P. Franks, and K. Shingu (2006)
Anesth. Analg. 103, 1459-1463
 |  Abstract »  |  Full Text »  |  PDF »

Plasticity of Both Excitatory and Inhibitory Synapses Is Associated With Seizures Induced by Removal of Chronic Blockade of Activity in Cultured Hippocampus.

S. B. Bausch, S. He, Y. Petrova, X.-M. Wang, and J. O. McNamara (2006)
J Neurophysiol 96, 2151-2167
 |  Abstract »  |  Full Text »  |  PDF »

Ketamine and thiopental sodium: individual and combined neuroprotective effects on cortical cultures exposed to NMDA or nitric oxide.

S. Shibuta, S. Varathan, and T. Mashimo (2006)
Br. J. Anaesth. 97, 517-524
 |  Abstract »  |  Full Text »  |  PDF »

Effect of Ketamine on Dendritic Arbor Development and Survival of Immature GABAergic Neurons In Vitro.

L. Vutskits, E. Gascon, E. Tassonyi, and J. Z. Kiss (2006)
Toxicol. Sci. 91, 540-549
 |  Abstract »  |  Full Text »  |  PDF »

Low Doses of Memantine Disrupt Memory in Adult Rats.

C. Creeley, D. F. Wozniak, J. Labruyere, G. T. Taylor, and J. W. Olney (2006)
J. Neurosci. 26, 3923-3932
 |  Abstract »  |  Full Text »  |  PDF »

Pharmacokinetics of S(+) ketamine derived from target controlled infusion.

M. White, P. de Graaff, B. Renshof, E. van Kan, and M. Dzoljic (2006)
Br. J. Anaesth. 96, 330-334
 |  Abstract »  |  Full Text »  |  PDF »

Assessment of Neuroprotective Effects of Glutamate Modulation on Glaucoma-Related Retinal Ganglion Cell Apoptosis In Vivo.

L. Guo, T. E. Salt, A. Maass, V. Luong, S. E. Moss, F. W. Fitzke, and M. F. Cordeiro (2006)
Invest. Ophthalmol. Vis. Sci. 47, 626-633
 |  Abstract »  |  Full Text »  |  PDF »

Neuroprotection against ischaemic brain injury by a GluR6-9c peptide containing the TAT protein transduction sequence.

D.-S. Pei, X.-T. Wang, Y. Liu, Y.-F. Sun, Q.-H. Guan, W. Wang, J.-Z. Yan, Y.-Y. Zong, T.-L. Xu, and G.-Y. Zhang (2006)
Brain 129, 465-479
 |  Abstract »  |  Full Text »  |  PDF »

Isoflurane-Induced Neuronal Degeneration: An Evaluation in Organotypic Hippocampal Slice Cultures.

L. Wise-Faberowski, H. Zhang, R. Ing, R. D. Pearlstein, and D. S. Warner (2005)
Anesth. Analg. 101, 651-657
 |  Abstract »  |  Full Text »  |  PDF »

Xenon: elemental anaesthesia in clinical practice.

R. D. Sanders, D. Ma, and M. Maze (2005)
Br. Med. Bull. 71, 115-135
 |  Abstract »  |  Full Text »  |  PDF »

Is Intrathecal Magnesium Sulfate Safe and Protective Against Ischemic Spinal Cord Injury in Rabbits?.

H. Saeki, M. Matsumoto, S. Kaneko, S. Tsuruta, Y. Jun Cui, K. Ohtake, K. Ishida, and T. Sakabe (2004)
Anesth. Analg. 99, 1805-1812
 |  Abstract »  |  Full Text »  |  PDF »

Hypoglycemic Neuronal Death and Cognitive Impairment Are Prevented by Poly(ADP-Ribose) Polymerase Inhibitors Administered after Hypoglycemia.

S. W. Suh, K. Aoyama, Y. Chen, P. Garnier, Y. Matsumori, E. Gum, J. Liu, and R. A. Swanson (2003)
J. Neurosci. 23, 10681-10690
 |  Abstract »  |  Full Text »  |  PDF »

Xenon: no stranger to anaesthesia.

R. D. Sanders, N. P. Franks, and M. Maze (2003)
Br. J. Anaesth. 91, 709-717
 |  Abstract »  |  Full Text »  |  PDF »

Functional Characterization of YM928, a Novel Noncompetitive {alpha}-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Antagonist.

K. Ohno, R. Tsutsumi, N. Matsumoto, H. Yamashita, Y. Amada, J.-I. Shishikura, H. I. S.-I. Yatsugi, M. Okada, S. Sakamoto, and T. Yamaguchi (2003)
J. Pharmacol. Exp. Ther. 306, 66-72
 |  Abstract »  |  Full Text »  |  PDF »

Neuroprotective {kappa}-Opioid Receptor Agonist BRL 52537 Attenuates Ischemia-Evoked Nitric Oxide Production In Vivo in Rats.

T. Goyagi, T. J.K. Toung, J. R. Kirsch, R. J. Traystman, R. C. Koehler, P. D. Hurn, and A. Bhardwaj (2003)
Stroke 34, 1533-1538
 |  Abstract »  |  Full Text »  |  PDF »

White Matter Changes in Schizophrenia: Evidence for Myelin-Related Dysfunction.

K. L. Davis, D. G. Stewart, J. I. Friedman, M. Buchsbaum, P. D. Harvey, P. R. Hof, J. Buxbaum, and V. Haroutunian (2003)
Arch Gen Psychiatry 60, 443-456
 |  Abstract »  |  Full Text »  |  PDF »

The Novel Neuroprotective Action of Sulfasalazine through Blockade of NMDA Receptors.

B. R. Ryu, Y. A. Lee, S. J. Won, J.-H. Noh, S.-Y. Chang, J.-M. Chung, J. S. Choi, C. K. Joo, S. H. Yoon, and B. J. Gwag (2003)
J. Pharmacol. Exp. Ther. 305, 48-56
 |  Abstract »  |  Full Text »

Nitric oxide signaling specificity -- the heart of the problem.

D. S. Bredt (2003)
J. Cell Sci. 116, 9-15
 |  Abstract »  |  Full Text »  |  PDF »

Blockade of Phencyclidine-Induced Cortical Apoptosis and Deficits in Prepulse Inhibition by M40403, a Superoxide Dismutase Mimetic.

C. Wang, J. McInnis, J. B. West, J. Bao, N. Anastasio, J. A. Guidry, Y. Ye, D. Salvemini, and K. M. Johnson (2003)
J. Pharmacol. Exp. Ther. 304, 266-271
 |  Abstract »  |  Full Text »  |  PDF »

Neuroprotective and neurotoxic properties of the 'inert' gas, xenon.

D. Ma, S. Wilhelm, M. Maze, and N. P. Franks (2002)
Br. J. Anaesth. 89, 739-746
 |  Abstract »  |  Full Text »  |  PDF »

Pharmacological Characterization of Ro 63-1908 (1-[2-(4-Hydroxy-phenoxy)-ethyl]-4-(4-methyl-benzyl)-piperidin-4-ol), a Novel Subtype-Selective N-Methyl-D-Aspartate Antagonist.

R. Gill, A. Alanine, A. Bourson, B. Buttelmann, G. Fischer, M.-P. Heitz, J. N. C. Kew, B. Levet-Trafit, H.-P. Lorez, P. Malherbe, et al. (2002)
J. Pharmacol. Exp. Ther. 302, 940-948
 |  Abstract »  |  Full Text »  |  PDF »

Ontogeny of the N-Methyl-D-Aspartate (NMDA) Receptor System and Susceptibility to Neurotoxicity.

K. A. Haberny, M. G. Paule, A. C. Scallet, F. D. Sistare, D. S. Lester, J. P. Hanig, and W. Slikker Jr. (2002)
Toxicol. Sci. 68, 9-17
 |  Abstract »  |  Full Text »  |  PDF »

Acetylcholine Receptors Do Not Mediate the Immobilization Produced by Inhaled Anesthetics.

E. I Eger II, Y. Zhang, M. Laster, P. Flood, J. J. Kendig, and J. M. Sonner (2002)
Anesth. Analg. 94, 1500-1504
 |  Abstract »  |  Full Text »  |  PDF »

NMDA Receptor Antagonists Disinhibit Rat Posterior Cingulate and Retrosplenial Cortices: A Potential Mechanism of Neurotoxicity.

Q. Li, S. Clark, D. V. Lewis, and W. A. Wilson (2002)
J. Neurosci. 22, 3070-3080
 |  Abstract »  |  Full Text »  |  PDF »

Structural Modifications to an N-Methyl-D-aspartate Receptor Antagonist Result in Large Differences in Trapping Block.

G. A. R. Mealing, T. H. Lanthorn, D. L. Small, R. J. Murray, K. C. Mattes, T. M. Comas, and P. Morley (2001)
J. Pharmacol. Exp. Ther. 297, 906-914
 |  Abstract »  |  Full Text »

Pharmacological Characterization of Locomotor Sensitization Induced by Chronic Phencyclidine Administration.

M. Phillips, C. Wang, and K. M. Johnson (2001)
J. Pharmacol. Exp. Ther. 296, 905-913
 |  Abstract »  |  Full Text »

Xenon Inhibits but N2O Enhances Ketamine-Induced c-Fos Expression in the Rat Posterior Cingulate and Retrosplenial Cortices.

A. Nagata, S.-i. Nakao, N. Nishizawa, M. Masuzawa, T. Inada, K. Murao, E. Miyamoto, and K. Shingu (2001)
Anesth. Analg. 92, 362-368
 |  Abstract »  |  Full Text »  |  PDF »

mGluR5 Antagonists 2-Methyl-6-(phenylethynyl)-pyridine and (E)-2-Methyl-6-(2-phenylethenyl)-pyridine Reduce Traumatic Neuronal Injury In Vitro and In Vivo by Antagonizing N-Methyl-D-aspartate Receptors.

V. A. Movsesyan, D. M. O'Leary, L. Fan, W. Bao, P. G. M. Mullins, S. M. Knoblach, and A. I. Faden (2001)
J. Pharmacol. Exp. Ther. 296, 41-47
 |  Abstract »  |  Full Text »

Exogenous aspartate neurotoxicity in the spinal cord under metabolic stress in vivo.

Y. Cho, T. Ueda, A. Mori, T. Nakamichi, H. Shimizu, Y. Inoue, and S. Kawada (2000)
Ann. Thorac. Surg. 70, 1496-1500
 |  Abstract »  |  Full Text »  |  PDF »

Ischemic spinal cord injury induced by aortic cross-clamping: prevention by riluzole.

L. Lang-Lazdunski, C. Heurteaux, A. Mignon, J. Mantz, C. Widmann, J.-M. Desmonts, and M. Lazdunski (2000)
Eur. J. Cardiothorac. Surg. 18, 174-181
 |  Abstract »  |  Full Text »  |  PDF »

{sigma}1-Receptor Ligand 4-Phenyl-1-(4-Phenylbutyl)-Piperidine Affords Neuroprotection From Focal Ischemia With Prolonged Reperfusion • Editorial Comment.

I. Harukuni, A. Bhardwaj, A. B. Shaivitz, A. C. DeVries, E. D. London, P. D. Hurn, R. J. Traystman, J. R. Kirsch, and F. M. Faraci (2000)
Stroke 31, 976-982
 |  Abstract »  |  Full Text »  |  PDF »

MK-801 Neurotoxicity in Cupric Silver-Stained Sections: Lesion Reconstruction by 3-Dimensional Computer Image Analysis.

A. S. Fix, S. R. Stitzel, G. M. Ridder, and R. C. Switzer (2000)
Toxicol Pathol 28, 84-90
 |  Abstract »  |  PDF »

Fluoro-Jade: Novel Fluorochromes for Detecting Toxicant-Induced Neuronal Degeneration.

L. C. Schmued and K. J. Hopkins (2000)
Toxicol Pathol 28, 91-99
 |  Abstract »  |  PDF »

Novel Structure Having Antagonist Actions at Both the Glycine Site of the N-Methyl-D-Aspartate Receptor and Neuronal Voltage-Sensitive Sodium Channels: Biochemical, Electrophysiological, and Behavioral Characterization.

L. D. Snell, D. J. Claffey, J. A. Ruth, C. F. Valenzuela, R. Cardoso, Z. Wang, S. R. Levinson, W. A. Sather, A. V. Williamson, N. C. Ingersoll, et al. (2000)
J. Pharmacol. Exp. Ther. 292, 215-227
 |  Abstract »  |  Full Text »

Stress Proteins as Molecular Markers of Neurotoxicity.

S. Rajdev and F. R. Sharp (2000)
Toxicol Pathol 28, 105-112
 |  Abstract »  |  PDF »

Ischemic Cell Death in Brain Neurons.

P. Lipton (1999)
Physiol Rev 79, 1431-1568
 |  Abstract »  |  Full Text »  |  PDF »

Sexual Dimorphism in Phencyclidine In Vitro Metabolism and Pharmacokinetics in Rats.

S. R. Shelnutt, M. Gunnell, and S. M. Owens (1999)
J. Pharmacol. Exp. Ther. 290, 1292-1298
 |  Abstract »  |  Full Text »

Expression of Cyclooxygenase-2 mRNA After Global Ischemia Is Regulated by AMPA Receptors and Glucocorticoids • Editorial Comment.

J. Koistinaho, S. Koponen, P. H. Chan, and C. Y. Hsu (1999)
Stroke 30, 1900-1906
 |  Abstract »  |  Full Text »  |  PDF »

RILUZOLE PREVENTS ISCHEMIC SPINAL CORD INJURY CAUSED BY AORTIC CROSSCLAMPING.

L. Lang-Lazdunski, C. Heurteaux, N. Vaillant, C. Widmann, and M. Lazdunski (1999)
J. Thorac. Cardiovasc. Surg. 117, 881-889
 |  Abstract »  |  Full Text »  |  PDF »

Dose Escalation Study of the NMDA Glycine-Site Antagonist Licostinel in Acute Ischemic Stroke.

G. W. Albers, W. M. Clark, R. P. Atkinson, K. Madden, J. L. Data, and M. J. Whitehouse (1999)
Stroke 30, 508-513
 |  Abstract »  |  Full Text »  |  PDF »

Differences in Degree of Trapping of Low-Affinity Uncompetitive N-Methyl-D-aspartic Acid Receptor Antagonists with Similar Kinetics of Block.

G. A. R. Mealing, T. H. Lanthorn, C. L. Murray, D. L. Small, and P. Morley (1999)
J. Pharmacol. Exp. Ther. 288, 204-210
 |  Abstract »  |  Full Text »

Effects of 5-Hydroxytryptamine2 Receptor Antagonism on the Behavioral Activation and Immediate Early Gene Expression Induced by Dizocilpine.

M. F. O'Neill, C. A. Hicks, G. Shaw, T. Parameswaran, G. P. Cardwell, and M. J. O'Neill (1998)
J. Pharmacol. Exp. Ther. 287, 839-846
 |  Abstract »  |  Full Text »

Glycine and N-Methyl-D-Aspartate Receptors: Physiological Significance and Possible Therapeutic Applications.

W. Danysz and C. G. Parsons (1998)
Pharmacol. Rev. 50, 597-664
 |  Abstract »  |  Full Text »  |  PDF »

Multiple Limbic Regions Mediate the Disruption of Prepulse Inhibition Produced in Rats by the Noncompetitive NMDA Antagonist Dizocilpine.

V. P. Bakshi and M. A. Geyer (1998)
J. Neurosci. 18, 8394-8401
 |  Abstract »  |  Full Text »  |  PDF »

ZK200775: A phosphonate quinoxalinedione AMPA antagonist for neuroprotection in stroke and trauma.

L. Turski, A. Huth, M. Sheardown, F. McDonald, R. Neuhaus, H. H. Schneider, U. Dirnagl, F. Wiegand, P. Jacobsen, and E. Ottow (1998)
PNAS 95, 10960-10965
 |  Abstract »  |  Full Text »  |  PDF »

Ethical Challenges in Stroke Research.

H. Slyter (1998)
Stroke 29, 1725-1729
 |  Abstract »  |  Full Text »  |  PDF »

Treatment With the Competitive NMDA Antagonist GPI 3000 Does Not Improve Outcome After Cardiac Arrest in Dogs • Editorial Comment.

M. A. Helfaer, R. N. Ichord, L. J. Martin, P. D. Hurn, A. Castro, R. J. Traystman, and G. Feuerstein (1998)
Stroke 29, 824-829
 |  Abstract »  |  Full Text »  |  PDF »

YM872, a Novel Selective alpha -Amino-3-hydroxy-5-methylisoxazole-4-propionic Acid Receptor Antagonist, Reduces Brain Damage after Permanent Focal Cerebral Ischemia in Cats.

M. Takahashi, J. W. Ni, S. Kawasaki-Yatsugi, T. Toya, S.-I. Yatsugi, M. Shimizu-Sasamata, K. Koshiya, J.-I. Shishikura, S. Sakamoto, and T. Yamaguchi (1998)
J. Pharmacol. Exp. Ther. 284, 467-473
 |  Abstract »  |  Full Text »

REVIEW {blacksquare} : Long-lasting Effects of Recreational Drugs of Abuse on the Central Nervous System.

U. D. McCann, K. A. Lowe, and G. A. Ricaurte (1997)
Neuroscientist 3, 399-411
 |  Abstract »  |  PDF »

Excitotoxic Neurodegeneration in Alzheimer Disease: New Hypothesis and New Therapeutic Strategies.

J. W. Olney, D. F. Wozniak, and N. B. Farber (1997)
Arch Neurol 54, 1234-1240
 |  Abstract »  |  PDF »

N-Methyl-D-Aspartate Receptor Hypofunction in Schizophrenia Could Arise From Reduced Cortical Connectivity Rather Than Receptor Dysfunction.

R. E. Hoffman and T. H. McGlashan (1997)
Arch Gen Psychiatry 54, 578-579
 |  Abstract »  |  PDF »

N-Methyl-D-Aspartate Receptors in Associative Eyeblink Conditioning: Both MK-801 and Phencyclidine Produce Task- and Dose-Dependent Impairments.

L. T. Thompson and J. F. Disterhoft (1997)
J. Pharmacol. Exp. Ther. 281, 928-940
 |  Abstract »  |  Full Text »

Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex.

B. Moghaddam, B. Adams, A. Verma, and D. Daly (1997)
J. Neurosci. 17, 2921-2927
 |  Abstract »  |  Full Text »  |  PDF »

Antagonism of N-Methyl-D-aspartate-evoked Currents in Rat Cortical Cultures by ARL 15896AR.

G. A. R. Mealing, T. H. Lanthorn, D. L. Small, M. A. Black, N. B. Laferriere, and P. Morley (1997)
J. Pharmacol. Exp. Ther. 281, 376-383
 |  Abstract »  |  Full Text »

Lack of Neuronal Vacuolation and Necrosis in Monkeys Treated with Selfotel (CGS 19755), A Competitive N-methyl-D-aspartate Receptor Antagonist.

K. R. Huber, P. S. Sahota, J. Kapeghian, H. H. Hsu, K. Amemiya, A. T. Arthur, S. L. Tripp, and V. M. Traina (1997)
International Journal of Toxicology 16, 175-181
 |  Abstract »  |  PDF »

Parallel Antioxidant and Antiexcitotoxic Therapy Improves Outcome After Incomplete Global Cerebral Ischemia in Dogs.

S. Davis, M. A. Helfaer, R. J. Traystman, P. D. Hurn, and P. H. Chan (1997)
Stroke 28, 198-205
 |  Abstract »  |  Full Text »

Considerations in the Design of Clinical Trials of Neuroprotective Therapy in Acute Stroke.

P. J. Dorman and P. A.G. Sandercock (1996)
Stroke 27, 1507-1515
 |  Full Text »

Amphetamine and Dopamine-Induced Immediate Early Gene Expression in Striatal Neurons Depends on Postsynaptic NMDA Receptors and Calcium.

C. Konradi, J.-C. Leveque, and S. E. Hyman (1996)
J. Neurosci. 16, 4231-4239
 |  Abstract »  |  Full Text »  |  PDF »

Felbamate Protects CA1 Neurons From Apoptosis in a Gerbil Model of Global Ischemia.

C. G. Wasterlain, L. M. Adams, J. K. Wichmann, R. D. Sofia, and J. MacManus (1996)
Stroke 27, 1236-1240
 |  Abstract »  |  Full Text »

Integrated Evaluation of Central Nervous System Lesions: Stains for Neurons, Astrocytes, and Microglia Reveal the Spatial and Temporal Features of MK-801-induced Neuronal Necrosis in the Rat Cerebral Cortex.

A. S. Fix, J. F. Ross, S. R. Stitzel, and R. C. Switzer (1996)
Toxicol Pathol 24, 291-304
 |  Abstract »  |  PDF »

Effect of Age and Sex on N-Methyl-D-Aspartate Antagonist-Induced Neuronal Necrosis in Rats.

R. N. Auer (1996)
Stroke 27, 743-746
 |  Abstract »  |  Full Text »

Glutamate Receptor Dysfunction and Schizophrenia.

J. W. Olney and N. B. Farber (1995)
Arch Gen Psychiatry 52, 998-1007
 |  Abstract »  |  PDF »

REVIEW {blacksquare} : Neuroprotection in Brain Ischemia: An Update (Part I.

M. D. Ginsberg (1995)
Neuroscientist 1, 95-103
 |  Abstract »  |  PDF »

AMPA Glutamate Receptor Antagonism Reduces Neurologic Injury After Hypothermic Circulatory Arrest.

J. M. Redmond, K. J. Zehr, M. E. Blue, M. S. Lange, A. M. Gillinov, J. C. Troncoso, D. E. Cameron, M. V. Johnston, and W. A. Baumgartner (1995)
Ann. Thorac. Surg. 59, 579-584
 |  Abstract »  |  Full Text »

Clinical Experience With Excitatory Amino Acid Antagonist Drugs.

K. W. Muir and K. R. Lees (1995)
Stroke 26, 503-513
 |  Abstract »  |  Full Text »

Prevention of Apoptotic Neuronal Death by G[IMAGE] Ganglioside.

G. Ferrari, B. L. Anderson, R. M. Stephens, D. R. Kaplan, and L. A. Greene (1995)
J. Biol. Chem. 270, 3074-3080
 |  Abstract »  |  Full Text »  |  PDF »

Safety, Tolerability, and Pharmacokinetics of the N-Methyl-D-Aspartate Antagonist Dextrorphan in Patients With Acute Stroke.

G.W. Albers, R.P. Atkinson, R.E. Kelley, and D.M. Rosenbaum (1995)
Stroke 26, 254-258
 |  Abstract »  |  Full Text »

Secondary Neuronal Injury After Head Trauma: Role of Excitotoxicity.

D. W. Choi (1995)
Neurorehabil Neural Repair 9, 61-64
 |  PDF »

Schizophrenia.

W. T. Carpenter and R. W. Buchanan (1994)
N. Engl. J. Med. 330, 681-690
 |  Full Text »

Glutamate excitotoxicity: A mechanism of neurologic injury associated with hypothermic circulatory arrest.

J. M. Redmond, A. M. Gillinov, K. J. Zehr, M. E. Blue, J. C. Troncoso, B. A. Reitz, D. E. Cameron, M. V. Johnston, and W. A. Baumgartner (1994)
J. Thorac. Cardiovasc. Surg. 107, 776-787
 |  Abstract »  |  Full Text »

Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans: Psychotomimetic, Perceptual, Cognitive, and Neuroendocrine Responses.

J. H. Krystal, L. P. Karper, J. P. Seibyl, G. K. Freeman, R. Delaney, J. D. Bremner, G. R. Heninger, M. B. Bowers Jr, and D. S. Charney (1994)
Arch Gen Psychiatry 51, 199-214
 |  Abstract »  |  PDF »

Evolving Toward Effective Therapy for Acute Ischemic Stroke.

M. Fisher and J. Bogousslavsky (1993)
JAMA 270, 360-364
 |  Abstract »  |  PDF »

Do NMDA Antagonists Prevent Neuronal Injury? Yes..

G. W. Albers, M. P. Goldberg, and D. W. Choi (1992)
Arch Neurol 49, 418-420
 |  Abstract »  |  PDF »

Do NMDA Antagonists Prevent Neuronal Injury? No..

A. M. Buchan (1992)
Arch Neurol 49, 420-421
 |  Abstract »  |  PDF »

NMDA antagonist neurotoxicity: mechanism and prevention.

J. Olney, J Labruyere, G Wang, D. Wozniak, M. Price, and M. Sesma (1991)
Science 254, 1515-1518
 |  Abstract »  |  PDF »

Overview of Approaches to In Vitro Neurotoxicity Testing.

M. Halks-Miller, V. Fedor, and C. A. Tyson (1991)
International Journal of Toxicology 10, 727-736
 |  PDF »

N-Methyl-d-Aspartate Antagonists in the Treatment of Parkinson's Disease.

J. T. Greenamyre and C. F. O'Brien (1991)
Arch Neurol 48, 977-981
 |  Abstract »  |  PDF »

Prevention and management of stroke.

J. C Grotta (1991)
Vascular Medicine 2, 3-17
 |  PDF »

Drug policy: striking the right balance.

A Goldstein and H Kalant (1990)
Science 249, 1513-1521
 |  Abstract »  |  PDF »

Neuronal death enhanced by N-methyl-D-aspartate antagonists.

C. Ikonomidou, V. Stefovska, and L. Turski (2000)
PNAS 97, 12885-12890
 |  Abstract »  |  Full Text »  |  PDF »

To Advertise   |   Find Products